Preoperative Hepatic Arterial Infusion Chemotherapy
1 other identifier
observational
N/A
1 country
1
Brief Summary
To assess the feasibility and results of liver resection after preoperative hepatic artery infusion (HAI) chemotherapy with FUDR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 1995
CompletedFirst Submitted
Initial submission to the registry
August 28, 2007
CompletedFirst Posted
Study publicly available on registry
August 29, 2007
CompletedAugust 29, 2007
May 1, 2007
August 28, 2007
August 28, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Unresectable liver metastases
- Potentially resectable liver metastases
You may not qualify if:
- Extrahepatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery - Liver Unit, Scientific Institute San Raffaele,
Milan, 20132, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Aldrighetti, M.D, PhD
Department of Surgery - Liver Unit, Scientific Institute San Raffaele,
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 28, 2007
First Posted
August 29, 2007
Study Start
December 1, 1995
Last Updated
August 29, 2007
Record last verified: 2007-05